Overview & Objectives

450 blue testtubes

 

The ultimate goal of Sydney Catalyst is to improve the outcomes of those affected by cancer or at risk of developing it, through discovery, new knowledge and the development and implementation of more effective cancer treatments, supportive care and preventative strategies.

To achieve this, we have established a translational cancer research program built on a broad cross-disciplinary team with skills in many areas including genomics, cancer biology/molecular oncology and molecular profiling, biobanking, bioinformatics, drug development, biostatistics and clinical epidemiology, as well as strong communication, education and operational strategies to ensure these diverse teams can work collaboratively and effectively.

The major goals and key objectives of Sydney Catalyst include;

Goal 1 - Develop and implement a comprehensive research program across the translational continuum - T1, T2 and T3. 

Key Objectives;

1.1 Develop and lead world class translational research through 3 flagship programs.

1.2 Support major translational research programs led by Sydney Catalyst members including CINSW schemes, other large state and federally funded programs.

1.3 Continue to build core competencies across the full spectrum of translational research. 

1.4 Build capacity in evidence into practice and implementation research to ensure the timely and efficient translation of evidence into practice. 

 

Goal 2 -Facilitate improved professional development, communication, and collaboration across the consortium.

Key Objective;

2.1 Build an engaged and active community of Sydney Catalyst members through a formal communication and collaboration strategy. 

2.2 Support the professional development, education and training of our members through a unique program of translational research learning opportunities. 

2.3 Support early- and mid-career researchers to develop outstanding careers in translational cancer research. 

2.4 Seek and receive feedback from members, collaborators and other key stakeholders on the success of the program and opportunities for development and improvement. 

 

Goal 3 - Build capacity in research, improve competitive advantage in securing other funds.

Key Objectives;

3.1 Facilitate improved research governance and contractual arrangements across the consortium.  

3.2 Identify and engage key stakeholders, using a range of specific research projects, activities and communication strategies to build and maintain effective partnerships.

3.3 Provide research support incl. concept development, tools to identify collaborators and resources, identification and incorporation of 'translation into practice' plans. 

3.4 Convene and facilitate themed Working Groups (WGs) to provide an important focus for advocacy of and expertise and activity in bench to bedside (T1/T2) research and evidence into practice (T2/T3) research. 

 

Goal 4 - Challenge the traditional, administrative and institutional barriers between clinicians and researchers to support a culture of embedding research and evidence in cancer healthcare.

Key Objective;

4.1 Facilitate local and systems change through active engagement with clinicians and health professionals across a range of disciplines, plus clinical leads and health services and managers, using specific projects and activities as exemplars for facilitating the translation of clinical problems into research questions and answers. 

4.2 Develop and support initiatives to bind researchers and clinicians in their routine work. 

4.3 Assess and describe the extent to which research is and can be embedded in healthcare.